vs
Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Creative Media & Community Trust Corp is the larger business by last-quarter revenue ($28.5M vs $18.3M, roughly 1.6× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -125.8%, a 122.7% gap on every dollar of revenue. On growth, Creative Media & Community Trust Corp posted the faster year-over-year revenue change (3.6% vs -25.6%). Over the past eight quarters, Creative Media & Community Trust Corp's revenue compounded faster (-8.5% CAGR vs -10.1%).
Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CMCT vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $28.5M | $18.3M |
| Net Profit | $-11.4M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | -125.6% | -2.2% |
| Net Margin | -125.8% | -3.0% |
| Revenue YoY | 3.6% | -25.6% |
| Net Profit YoY | -11.4% | 26.7% |
| EPS (diluted) | $-3.89 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $28.5M | $18.3M | ||
| Q3 25 | $26.2M | $15.9M | ||
| Q2 25 | $29.7M | $16.1M | ||
| Q1 25 | $32.3M | $18.9M | ||
| Q4 24 | $27.5M | $24.7M | ||
| Q3 24 | $28.6M | $28.3M | ||
| Q2 24 | $34.4M | $25.8M | ||
| Q1 24 | $34.0M | $22.7M |
| Q4 25 | $-11.4M | $-554.0K | ||
| Q3 25 | $-12.5M | $-1.8M | ||
| Q2 25 | $-9.0M | $-1.5M | ||
| Q1 25 | $-6.1M | $-1.5M | ||
| Q4 24 | $-10.3M | $-756.0K | ||
| Q3 24 | $-10.4M | $1.7M | ||
| Q2 24 | $-796.0K | $343.0K | ||
| Q1 24 | $-3.7M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | -125.6% | -2.2% | ||
| Q3 25 | -47.7% | -9.9% | ||
| Q2 25 | -30.3% | -8.4% | ||
| Q1 25 | -19.0% | -7.2% | ||
| Q4 24 | -128.8% | -2.1% | ||
| Q3 24 | -36.9% | 6.8% | ||
| Q2 24 | -1.6% | 2.0% | ||
| Q1 24 | -10.7% | -5.8% |
| Q4 25 | -125.8% | -3.0% | ||
| Q3 25 | -47.5% | -11.0% | ||
| Q2 25 | -30.3% | -9.3% | ||
| Q1 25 | -18.9% | -8.0% | ||
| Q4 24 | -129.8% | -3.1% | ||
| Q3 24 | -36.3% | 5.9% | ||
| Q2 24 | -2.3% | 1.3% | ||
| Q1 24 | -11.0% | -7.6% |
| Q4 25 | $-3.89 | $-0.01 | ||
| Q3 25 | $-23.52 | $-0.05 | ||
| Q2 25 | $-18.94 | $-0.05 | ||
| Q1 25 | $-20.73 | $-0.04 | ||
| Q4 24 | $97.71 | $-0.02 | ||
| Q3 24 | $-305.04 | $0.04 | ||
| Q2 24 | $-98.64 | $0.01 | ||
| Q1 24 | $-125.46 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.4M | $10.7M |
| Total DebtLower is stronger | $509.8M | — |
| Stockholders' EquityBook value | $265.4M | $37.0M |
| Total Assets | $859.2M | $57.1M |
| Debt / EquityLower = less leverage | 1.92× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.4M | $10.7M | ||
| Q3 25 | $17.3M | $13.6M | ||
| Q2 25 | $27.8M | $12.5M | ||
| Q1 25 | $19.8M | $11.4M | ||
| Q4 24 | $20.3M | $15.7M | ||
| Q3 24 | $18.5M | $12.3M | ||
| Q2 24 | $29.3M | $11.9M | ||
| Q1 24 | $21.3M | $6.6M |
| Q4 25 | $509.8M | — | ||
| Q3 25 | $527.8M | — | ||
| Q2 25 | $535.6M | — | ||
| Q1 25 | $512.7M | — | ||
| Q4 24 | $505.7M | — | ||
| Q3 24 | $478.3M | — | ||
| Q2 24 | $485.1M | — | ||
| Q1 24 | $472.8M | — |
| Q4 25 | $265.4M | $37.0M | ||
| Q3 25 | $281.9M | $37.0M | ||
| Q2 25 | $287.1M | $30.4M | ||
| Q1 25 | $293.0M | $31.5M | ||
| Q4 24 | $304.5M | $32.6M | ||
| Q3 24 | $321.0M | $29.1M | ||
| Q2 24 | $351.1M | $23.5M | ||
| Q1 24 | $369.9M | $20.6M |
| Q4 25 | $859.2M | $57.1M | ||
| Q3 25 | $871.8M | $57.5M | ||
| Q2 25 | $885.0M | $52.6M | ||
| Q1 25 | $882.3M | $54.0M | ||
| Q4 24 | $889.6M | $59.2M | ||
| Q3 24 | $868.0M | $57.1M | ||
| Q2 24 | $891.2M | $53.0M | ||
| Q1 24 | $887.5M | $50.7M |
| Q4 25 | 1.92× | — | ||
| Q3 25 | 1.87× | — | ||
| Q2 25 | 1.87× | — | ||
| Q1 25 | 1.75× | — | ||
| Q4 24 | 1.66× | — | ||
| Q3 24 | 1.49× | — | ||
| Q2 24 | 1.38× | — | ||
| Q1 24 | 1.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.8M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.8M | $2.3M | ||
| Q3 25 | $3.7M | $-1.3M | ||
| Q2 25 | $-2.5M | $1.8M | ||
| Q1 25 | $1.2M | $-3.5M | ||
| Q4 24 | $17.0M | $865.0K | ||
| Q3 24 | $10.3M | $4.3M | ||
| Q2 24 | $3.9M | $1.4M | ||
| Q1 24 | $1.6M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMCT
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
